^Arnemann J, Spurr NK, Wheeler GN, Parker AE, Buxton RS (Oct 1991). “Chromosomal assignment of the human genes coding for the major proteins of the desmosome junction, desmoglein DGI (DSG), desmocollins DGII/III (DSC), desmoplakins DPI/II (DSP), and plakoglobin DPIII (JUP)”. Genomics10 (3): 640-45. doi:10.1016/0888-7543(91)90446-L. PMID1889810.
^Chen X, Bonne S, Hatzfeld M, van Roy F, Green KJ (March 2002). “Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling”. J. Biol. Chem.277 (12): 10512-10522. doi:10.1074/jbc.M108765200. PMID11790773.
^Besco JA, Hooft van Huijsduijnen R, Frostholm A, Rotter A (2006). “Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT).”. Brain Res1116 (1): 50-57. doi:10.1016/j.brainres.2006.07.122. PMID16973135.
Amagai M, Klaus-Kovtun V, Stanley JR (1992). “Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion”. Cell67 (5): 869-877. doi:10.1016/0092-8674(91)90360-B. PMID1720352.
Martinez RD (1992). “[Characterization of the desmoglein in renal cells in culture] [Characterization of the desmoglein in renal cells in culture]” (Spanish). Revista alergia Mexico38 (2): 59-64. PMID1754823.
Nilles LA, Parry DA, Powers EE (1992). “Structural analysis and expression of human desmoglein: a cadherin-like component of the desmosome”. J. Cell. Sci.99 (4): 809-821. PMID1770008.
Roh JY, Stanley JR (1995). “Plakoglobin binding by human Dsg3 (pemphigus vulgaris antigen) in keratinocytes requires the cadherin-like intracytoplasmic segment”. J. Invest. Dermatol.104 (5): 720-724. doi:10.1111/1523-1747.ep12606963. PMID7738346.
Simrak D, Cowley CM, Buxton RS, Arnemann J (1995). “Tandem arrangement of the closely linked desmoglein genes on human chromosome 18”. Genomics25 (2): 591-594. doi:10.1016/0888-7543(95)80067-V. PMID7790000.
Wang Y, Amagai M, Minoshima S (1994). “The human genes for desmogleins (DSG1 and DSG3) are located in a small region on chromosome 18q12”. Genomics20 (3): 492-495. doi:10.1006/geno.1994.1207. PMID8034325.
Schafer S, Koch PJ, Franke WW (1994). “Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins”. Exp. Cell Res.211 (2): 391-399. doi:10.1006/excr.1994.1103. PMID8143788.
Marcozzi C, Burdett ID, Buxton RS, Magee AI (1998). “Coexpression of both types of desmosomal cadherin and plakoglobin confers strong intercellular adhesion”. J. Cell. Sci.111 (4): 495-509. PMID9443898.
Rickman L, Simrak D, Stevens HP (1999). “N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma”. Hum. Mol. Genet.8 (6): 971-976. doi:10.1093/hmg/8.6.971. PMID10332028.
Li G, Schaider H, Satyamoorthy K (2002). “Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development”. Oncogene20 (56): 8125-8135. doi:10.1038/sj.onc.1205034. PMID11781826.
Chen X, Bonne S, Hatzfeld M (2002). “Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling”. J. Biol. Chem.277 (12): 10512-10522. doi:10.1074/jbc.M108765200. PMID11790773.
Martel P, Gilbert D, Busson M (2003). “Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus”. Genes Immun.3 (4): 205-210. doi:10.1038/sj.gene.6363839. PMID12058255.
Hanakawa Y, Amagai M, Shirakata Y (2003). “Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation”. J. Invest. Dermatol.119 (6): 1231-1236. doi:10.1046/j.1523-1747.2002.19648.x. PMID12485422.